Emtricitabine/Tenofovir disoproxil Mylan

emtricitabine; tenofovir disoproxil maleate · Mylan Pharmaceuticals Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Emtricitabine/Tenofovir disoproxil Mylan, covering 2025-06-30 to 2025-06-30. Get the full timeline:

Most recent: EMA Authorised: Emtricitabine/Tenofovir disoproxil Mylan (emtricitabine;tenofovir disoproxil maleate) — Mylan Pharmaceuticals Limited